ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ophthalmic Drug Delivery System Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-31X9926
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Ophthalmic Drug Delivery System Market Research Report 2022
BUY CHAPTERS

Global Ophthalmic Drug Delivery System Market Research Report 2025

Code: QYRE-Auto-31X9926
Report
March 2025
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson& Company
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix
Owen Mumford
Silgan Holdings Inc.
Terumo Corporation
West Pharmaceutical Services, Inc.
Kedalion Therapeutics
Re-Vana Therapeutics
Mati Therapeutics, Inc.,
Biocorp Production
Ocumedic, Inc.
Graybug Vision
Taiwan Liposome
Santen Pharmaceutical
Envisia Therapeutics
Clearside Biomedical

Ophthalmic Drug Delivery System Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Ophthalmic Drug Delivery System Market

Ophthalmic Drug Delivery System Market

The global market for Ophthalmic Drug Delivery System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ophthalmic Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Drug Delivery System.
The Ophthalmic Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ophthalmic Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ophthalmic Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ophthalmic Drug Delivery System Market Report

Report Metric Details
Report Name Ophthalmic Drug Delivery System Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, Inc., Gaplast GmbH, Gerresheimer, Nemera, Nipro Corporation, Ocular Therapeutix, Owen Mumford, Silgan Holdings Inc., Terumo Corporation, West Pharmaceutical Services, Inc., Kedalion Therapeutics, Re-Vana Therapeutics, Mati Therapeutics, Inc.,, Biocorp Production, Ocumedic, Inc., Graybug Vision, Taiwan Liposome, Santen Pharmaceutical, Envisia Therapeutics, Clearside Biomedical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ophthalmic Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ophthalmic Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Ophthalmic Drug Delivery System Market report?

Ans: The main players in the Ophthalmic Drug Delivery System Market are Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, Inc., Gaplast GmbH, Gerresheimer, Nemera, Nipro Corporation, Ocular Therapeutix, Owen Mumford, Silgan Holdings Inc., Terumo Corporation, West Pharmaceutical Services, Inc., Kedalion Therapeutics, Re-Vana Therapeutics, Mati Therapeutics, Inc.,, Biocorp Production, Ocumedic, Inc., Graybug Vision, Taiwan Liposome, Santen Pharmaceutical, Envisia Therapeutics, Clearside Biomedical

What are the Application segmentation covered in the Ophthalmic Drug Delivery System Market report?

Ans: The Applications covered in the Ophthalmic Drug Delivery System Market report are Hospitals, Clinics, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Ophthalmic Drug Delivery System Market report?

Ans: The Types covered in the Ophthalmic Drug Delivery System Market report are Implantable Ophthalmic Drug Delivery Systems, Particulate Ophthalmic Drug Delivery Systems, Others

Recommended Reports

Ophthalmic Devices & Treatments

Drug Delivery Technologies

Ophthalmic Therapies & Disorders

1 Ophthalmic Drug Delivery System Market Overview
1.1 Product Definition
1.2 Ophthalmic Drug Delivery System by Type
1.2.1 Global Ophthalmic Drug Delivery System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Implantable Ophthalmic Drug Delivery Systems
1.2.3 Particulate Ophthalmic Drug Delivery Systems
1.2.4 Others
1.3 Ophthalmic Drug Delivery System by Application
1.3.1 Global Ophthalmic Drug Delivery System Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Ophthalmic Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Ophthalmic Drug Delivery System Revenue 2020-2031
1.4.2 Global Ophthalmic Drug Delivery System Sales 2020-2031
1.4.3 Global Ophthalmic Drug Delivery System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Ophthalmic Drug Delivery System Market Competition by Manufacturers
2.1 Global Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Ophthalmic Drug Delivery System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Ophthalmic Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ophthalmic Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ophthalmic Drug Delivery System, Product Type & Application
2.7 Global Key Manufacturers of Ophthalmic Drug Delivery System, Date of Enter into This Industry
2.8 Global Ophthalmic Drug Delivery System Market Competitive Situation and Trends
2.8.1 Global Ophthalmic Drug Delivery System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ophthalmic Drug Delivery System Players Market Share by Revenue
2.8.3 Global Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ophthalmic Drug Delivery System Market Scenario by Region
3.1 Global Ophthalmic Drug Delivery System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Ophthalmic Drug Delivery System Sales by Region: 2020-2031
3.2.1 Global Ophthalmic Drug Delivery System Sales by Region: 2020-2025
3.2.2 Global Ophthalmic Drug Delivery System Sales by Region: 2026-2031
3.3 Global Ophthalmic Drug Delivery System Revenue by Region: 2020-2031
3.3.1 Global Ophthalmic Drug Delivery System Revenue by Region: 2020-2025
3.3.2 Global Ophthalmic Drug Delivery System Revenue by Region: 2026-2031
3.4 North America Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.4.1 North America Ophthalmic Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Ophthalmic Drug Delivery System Sales by Country (2020-2031)
3.4.3 North America Ophthalmic Drug Delivery System Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe Ophthalmic Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Ophthalmic Drug Delivery System Sales by Country (2020-2031)
3.5.3 Europe Ophthalmic Drug Delivery System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ophthalmic Drug Delivery System Market Facts & Figures by Region
3.6.1 Asia Pacific Ophthalmic Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Ophthalmic Drug Delivery System Sales by Region (2020-2031)
3.6.3 Asia Pacific Ophthalmic Drug Delivery System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America Ophthalmic Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Ophthalmic Drug Delivery System Sales by Country (2020-2031)
3.7.3 Latin America Ophthalmic Drug Delivery System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Ophthalmic Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Ophthalmic Drug Delivery System Sales by Type (2020-2031)
4.1.1 Global Ophthalmic Drug Delivery System Sales by Type (2020-2025)
4.1.2 Global Ophthalmic Drug Delivery System Sales by Type (2026-2031)
4.1.3 Global Ophthalmic Drug Delivery System Sales Market Share by Type (2020-2031)
4.2 Global Ophthalmic Drug Delivery System Revenue by Type (2020-2031)
4.2.1 Global Ophthalmic Drug Delivery System Revenue by Type (2020-2025)
4.2.2 Global Ophthalmic Drug Delivery System Revenue by Type (2026-2031)
4.2.3 Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2020-2031)
4.3 Global Ophthalmic Drug Delivery System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Ophthalmic Drug Delivery System Sales by Application (2020-2031)
5.1.1 Global Ophthalmic Drug Delivery System Sales by Application (2020-2025)
5.1.2 Global Ophthalmic Drug Delivery System Sales by Application (2026-2031)
5.1.3 Global Ophthalmic Drug Delivery System Sales Market Share by Application (2020-2031)
5.2 Global Ophthalmic Drug Delivery System Revenue by Application (2020-2031)
5.2.1 Global Ophthalmic Drug Delivery System Revenue by Application (2020-2025)
5.2.2 Global Ophthalmic Drug Delivery System Revenue by Application (2026-2031)
5.2.3 Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2020-2031)
5.3 Global Ophthalmic Drug Delivery System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Aero Pump GmbH
6.1.1 Aero Pump GmbH Company Information
6.1.2 Aero Pump GmbH Description and Business Overview
6.1.3 Aero Pump GmbH Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Aero Pump GmbH Ophthalmic Drug Delivery System Product Portfolio
6.1.5 Aero Pump GmbH Recent Developments/Updates
6.2 AptarGroup
6.2.1 AptarGroup Company Information
6.2.2 AptarGroup Description and Business Overview
6.2.3 AptarGroup Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AptarGroup Ophthalmic Drug Delivery System Product Portfolio
6.2.5 AptarGroup Recent Developments/Updates
6.3 Bausch Health
6.3.1 Bausch Health Company Information
6.3.2 Bausch Health Description and Business Overview
6.3.3 Bausch Health Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bausch Health Ophthalmic Drug Delivery System Product Portfolio
6.3.5 Bausch Health Recent Developments/Updates
6.4 Becton Dickinson & Company
6.4.1 Becton Dickinson & Company Company Information
6.4.2 Becton Dickinson & Company Description and Business Overview
6.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery System Product Portfolio
6.4.5 Becton Dickinson & Company Recent Developments/Updates
6.5 EyePoint Pharmaceuticals, Inc.
6.5.1 EyePoint Pharmaceuticals, Inc. Company Information
6.5.2 EyePoint Pharmaceuticals, Inc. Description and Business Overview
6.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Portfolio
6.5.5 EyePoint Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Gaplast GmbH
6.6.1 Gaplast GmbH Company Information
6.6.2 Gaplast GmbH Description and Business Overview
6.6.3 Gaplast GmbH Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Gaplast GmbH Ophthalmic Drug Delivery System Product Portfolio
6.6.5 Gaplast GmbH Recent Developments/Updates
6.7 Gerresheimer
6.7.1 Gerresheimer Company Information
6.7.2 Gerresheimer Description and Business Overview
6.7.3 Gerresheimer Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Gerresheimer Ophthalmic Drug Delivery System Product Portfolio
6.7.5 Gerresheimer Recent Developments/Updates
6.8 Nemera
6.8.1 Nemera Company Information
6.8.2 Nemera Description and Business Overview
6.8.3 Nemera Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Nemera Ophthalmic Drug Delivery System Product Portfolio
6.8.5 Nemera Recent Developments/Updates
6.9 Nipro Corporation
6.9.1 Nipro Corporation Company Information
6.9.2 Nipro Corporation Description and Business Overview
6.9.3 Nipro Corporation Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nipro Corporation Ophthalmic Drug Delivery System Product Portfolio
6.9.5 Nipro Corporation Recent Developments/Updates
6.10 Ocular Therapeutix
6.10.1 Ocular Therapeutix Company Information
6.10.2 Ocular Therapeutix Description and Business Overview
6.10.3 Ocular Therapeutix Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Ocular Therapeutix Ophthalmic Drug Delivery System Product Portfolio
6.10.5 Ocular Therapeutix Recent Developments/Updates
6.11 Owen Mumford
6.11.1 Owen Mumford Company Information
6.11.2 Owen Mumford Description and Business Overview
6.11.3 Owen Mumford Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Owen Mumford Ophthalmic Drug Delivery System Product Portfolio
6.11.5 Owen Mumford Recent Developments/Updates
6.12 Silgan Holdings Inc.
6.12.1 Silgan Holdings Inc. Company Information
6.12.2 Silgan Holdings Inc. Description and Business Overview
6.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Portfolio
6.12.5 Silgan Holdings Inc. Recent Developments/Updates
6.13 Terumo Corporation
6.13.1 Terumo Corporation Company Information
6.13.2 Terumo Corporation Description and Business Overview
6.13.3 Terumo Corporation Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Terumo Corporation Ophthalmic Drug Delivery System Product Portfolio
6.13.5 Terumo Corporation Recent Developments/Updates
6.14 West Pharmaceutical Services, Inc.
6.14.1 West Pharmaceutical Services, Inc. Company Information
6.14.2 West Pharmaceutical Services, Inc. Description and Business Overview
6.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.14.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Portfolio
6.14.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
6.15 Kedalion Therapeutics
6.15.1 Kedalion Therapeutics Company Information
6.15.2 Kedalion Therapeutics Description and Business Overview
6.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Kedalion Therapeutics Ophthalmic Drug Delivery System Product Portfolio
6.15.5 Kedalion Therapeutics Recent Developments/Updates
6.16 Re-Vana Therapeutics
6.16.1 Re-Vana Therapeutics Company Information
6.16.2 Re-Vana Therapeutics Description and Business Overview
6.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Portfolio
6.16.5 Re-Vana Therapeutics Recent Developments/Updates
6.17 Mati Therapeutics, Inc.,
6.17.1 Mati Therapeutics, Inc., Company Information
6.17.2 Mati Therapeutics, Inc., Description and Business Overview
6.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Portfolio
6.17.5 Mati Therapeutics, Inc., Recent Developments/Updates
6.18 Biocorp Production
6.18.1 Biocorp Production Company Information
6.18.2 Biocorp Production Description and Business Overview
6.18.3 Biocorp Production Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Biocorp Production Ophthalmic Drug Delivery System Product Portfolio
6.18.5 Biocorp Production Recent Developments/Updates
6.19 Ocumedic, Inc.
6.19.1 Ocumedic, Inc. Company Information
6.19.2 Ocumedic, Inc. Description and Business Overview
6.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Ocumedic, Inc. Ophthalmic Drug Delivery System Product Portfolio
6.19.5 Ocumedic, Inc. Recent Developments/Updates
6.20 Graybug Vision
6.20.1 Graybug Vision Company Information
6.20.2 Graybug Vision Description and Business Overview
6.20.3 Graybug Vision Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Graybug Vision Ophthalmic Drug Delivery System Product Portfolio
6.20.5 Graybug Vision Recent Developments/Updates
6.21 Taiwan Liposome
6.21.1 Taiwan Liposome Company Information
6.21.2 Taiwan Liposome Description and Business Overview
6.21.3 Taiwan Liposome Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Taiwan Liposome Ophthalmic Drug Delivery System Product Portfolio
6.21.5 Taiwan Liposome Recent Developments/Updates
6.22 Santen Pharmaceutical
6.22.1 Santen Pharmaceutical Company Information
6.22.2 Santen Pharmaceutical Description and Business Overview
6.22.3 Santen Pharmaceutical Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Santen Pharmaceutical Ophthalmic Drug Delivery System Product Portfolio
6.22.5 Santen Pharmaceutical Recent Developments/Updates
6.23 Envisia Therapeutics
6.23.1 Envisia Therapeutics Company Information
6.23.2 Envisia Therapeutics Description and Business Overview
6.23.3 Envisia Therapeutics Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Envisia Therapeutics Ophthalmic Drug Delivery System Product Portfolio
6.23.5 Envisia Therapeutics Recent Developments/Updates
6.24 Clearside Biomedical
6.24.1 Clearside Biomedical Company Information
6.24.2 Clearside Biomedical Description and Business Overview
6.24.3 Clearside Biomedical Ophthalmic Drug Delivery System Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Clearside Biomedical Ophthalmic Drug Delivery System Product Portfolio
6.24.5 Clearside Biomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ophthalmic Drug Delivery System Industry Chain Analysis
7.2 Ophthalmic Drug Delivery System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ophthalmic Drug Delivery System Production Mode & Process Analysis
7.4 Ophthalmic Drug Delivery System Sales and Marketing
7.4.1 Ophthalmic Drug Delivery System Sales Channels
7.4.2 Ophthalmic Drug Delivery System Distributors
7.5 Ophthalmic Drug Delivery System Customer Analysis
8 Ophthalmic Drug Delivery System Market Dynamics
8.1 Ophthalmic Drug Delivery System Industry Trends
8.2 Ophthalmic Drug Delivery System Market Drivers
8.3 Ophthalmic Drug Delivery System Market Challenges
8.4 Ophthalmic Drug Delivery System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson& Company
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix
Owen Mumford
Silgan Holdings Inc.
Terumo Corporation
West Pharmaceutical Services, Inc.
Kedalion Therapeutics
Re-Vana Therapeutics
Mati Therapeutics, Inc.,
Biocorp Production
Ocumedic, Inc.
Graybug Vision
Taiwan Liposome
Santen Pharmaceutical
Envisia Therapeutics
Clearside Biomedical
List of Tables
 Table 1. Global Ophthalmic Drug Delivery System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Ophthalmic Drug Delivery System Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Ophthalmic Drug Delivery System Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Ophthalmic Drug Delivery System Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Ophthalmic Drug Delivery System Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Ophthalmic Drug Delivery System Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Ophthalmic Drug Delivery System Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Ophthalmic Drug Delivery System, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Ophthalmic Drug Delivery System, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Ophthalmic Drug Delivery System, Product Type & Application
 Table 12. Global Key Manufacturers of Ophthalmic Drug Delivery System, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ophthalmic Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Drug Delivery System as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ophthalmic Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Ophthalmic Drug Delivery System Sales by Region (2020-2025) & (K Units)
 Table 18. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2020-2025)
 Table 19. Global Ophthalmic Drug Delivery System Sales by Region (2026-2031) & (K Units)
 Table 20. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2026-2031)
 Table 21. Global Ophthalmic Drug Delivery System Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2020-2025)
 Table 23. Global Ophthalmic Drug Delivery System Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2026-2031)
 Table 25. North America Ophthalmic Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Ophthalmic Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 27. North America Ophthalmic Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 28. North America Ophthalmic Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Ophthalmic Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Ophthalmic Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Ophthalmic Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Ophthalmic Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Ophthalmic Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Ophthalmic Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Ophthalmic Drug Delivery System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Ophthalmic Drug Delivery System Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Ophthalmic Drug Delivery System Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Ophthalmic Drug Delivery System Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Ophthalmic Drug Delivery System Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Ophthalmic Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Ophthalmic Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Ophthalmic Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Ophthalmic Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Ophthalmic Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Ophthalmic Drug Delivery System Sales (K Units) by Type (2020-2025)
 Table 51. Global Ophthalmic Drug Delivery System Sales (K Units) by Type (2026-2031)
 Table 52. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2020-2025)
 Table 53. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2026-2031)
 Table 54. Global Ophthalmic Drug Delivery System Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Ophthalmic Drug Delivery System Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2020-2025)
 Table 57. Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2026-2031)
 Table 58. Global Ophthalmic Drug Delivery System Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Ophthalmic Drug Delivery System Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Ophthalmic Drug Delivery System Sales (K Units) by Application (2020-2025)
 Table 61. Global Ophthalmic Drug Delivery System Sales (K Units) by Application (2026-2031)
 Table 62. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2020-2025)
 Table 63. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2026-2031)
 Table 64. Global Ophthalmic Drug Delivery System Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Ophthalmic Drug Delivery System Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2020-2025)
 Table 67. Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2026-2031)
 Table 68. Global Ophthalmic Drug Delivery System Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Ophthalmic Drug Delivery System Price (US$/Unit) by Application (2026-2031)
 Table 70. Aero Pump GmbH Company Information
 Table 71. Aero Pump GmbH Description and Business Overview
 Table 72. Aero Pump GmbH Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Aero Pump GmbH Ophthalmic Drug Delivery System Product
 Table 74. Aero Pump GmbH Recent Developments/Updates
 Table 75. AptarGroup Company Information
 Table 76. AptarGroup Description and Business Overview
 Table 77. AptarGroup Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. AptarGroup Ophthalmic Drug Delivery System Product
 Table 79. AptarGroup Recent Developments/Updates
 Table 80. Bausch Health Company Information
 Table 81. Bausch Health Description and Business Overview
 Table 82. Bausch Health Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Bausch Health Ophthalmic Drug Delivery System Product
 Table 84. Bausch Health Recent Developments/Updates
 Table 85. Becton Dickinson & Company Company Information
 Table 86. Becton Dickinson & Company Description and Business Overview
 Table 87. Becton Dickinson & Company Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Becton Dickinson & Company Ophthalmic Drug Delivery System Product
 Table 89. Becton Dickinson & Company Recent Developments/Updates
 Table 90. EyePoint Pharmaceuticals, Inc. Company Information
 Table 91. EyePoint Pharmaceuticals, Inc. Description and Business Overview
 Table 92. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product
 Table 94. EyePoint Pharmaceuticals, Inc. Recent Developments/Updates
 Table 95. Gaplast GmbH Company Information
 Table 96. Gaplast GmbH Description and Business Overview
 Table 97. Gaplast GmbH Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Gaplast GmbH Ophthalmic Drug Delivery System Product
 Table 99. Gaplast GmbH Recent Developments/Updates
 Table 100. Gerresheimer Company Information
 Table 101. Gerresheimer Description and Business Overview
 Table 102. Gerresheimer Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Gerresheimer Ophthalmic Drug Delivery System Product
 Table 104. Gerresheimer Recent Developments/Updates
 Table 105. Nemera Company Information
 Table 106. Nemera Description and Business Overview
 Table 107. Nemera Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Nemera Ophthalmic Drug Delivery System Product
 Table 109. Nemera Recent Developments/Updates
 Table 110. Nipro Corporation Company Information
 Table 111. Nipro Corporation Description and Business Overview
 Table 112. Nipro Corporation Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Nipro Corporation Ophthalmic Drug Delivery System Product
 Table 114. Nipro Corporation Recent Developments/Updates
 Table 115. Ocular Therapeutix Company Information
 Table 116. Ocular Therapeutix Description and Business Overview
 Table 117. Ocular Therapeutix Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Ocular Therapeutix Ophthalmic Drug Delivery System Product
 Table 119. Ocular Therapeutix Recent Developments/Updates
 Table 120. Owen Mumford Company Information
 Table 121. Owen Mumford Description and Business Overview
 Table 122. Owen Mumford Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Owen Mumford Ophthalmic Drug Delivery System Product
 Table 124. Owen Mumford Recent Developments/Updates
 Table 125. Silgan Holdings Inc. Company Information
 Table 126. Silgan Holdings Inc. Description and Business Overview
 Table 127. Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Silgan Holdings Inc. Ophthalmic Drug Delivery System Product
 Table 129. Silgan Holdings Inc. Recent Developments/Updates
 Table 130. Terumo Corporation Company Information
 Table 131. Terumo Corporation Description and Business Overview
 Table 132. Terumo Corporation Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Terumo Corporation Ophthalmic Drug Delivery System Product
 Table 134. Terumo Corporation Recent Developments/Updates
 Table 135. West Pharmaceutical Services, Inc. Company Information
 Table 136. West Pharmaceutical Services, Inc. Description and Business Overview
 Table 137. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product
 Table 139. West Pharmaceutical Services, Inc. Recent Developments/Updates
 Table 140. Kedalion Therapeutics Company Information
 Table 141. Kedalion Therapeutics Description and Business Overview
 Table 142. Kedalion Therapeutics Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Kedalion Therapeutics Ophthalmic Drug Delivery System Product
 Table 144. Kedalion Therapeutics Recent Developments/Updates
 Table 145. Re-Vana Therapeutics Company Information
 Table 146. Re-Vana Therapeutics Description and Business Overview
 Table 147. Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Re-Vana Therapeutics Ophthalmic Drug Delivery System Product
 Table 149. Re-Vana Therapeutics Recent Developments/Updates
 Table 150. Mati Therapeutics, Inc., Company Information
 Table 151. Mati Therapeutics, Inc., Description and Business Overview
 Table 152. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product
 Table 154. Mati Therapeutics, Inc., Recent Developments/Updates
 Table 155. Biocorp Production Company Information
 Table 156. Biocorp Production Description and Business Overview
 Table 157. Biocorp Production Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Biocorp Production Ophthalmic Drug Delivery System Product
 Table 159. Biocorp Production Recent Developments/Updates
 Table 160. Ocumedic, Inc. Company Information
 Table 161. Ocumedic, Inc. Description and Business Overview
 Table 162. Ocumedic, Inc. Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Ocumedic, Inc. Ophthalmic Drug Delivery System Product
 Table 164. Ocumedic, Inc. Recent Developments/Updates
 Table 165. Graybug Vision Company Information
 Table 166. Graybug Vision Description and Business Overview
 Table 167. Graybug Vision Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Graybug Vision Ophthalmic Drug Delivery System Product
 Table 169. Graybug Vision Recent Developments/Updates
 Table 170. Taiwan Liposome Company Information
 Table 171. Taiwan Liposome Description and Business Overview
 Table 172. Taiwan Liposome Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Taiwan Liposome Ophthalmic Drug Delivery System Product
 Table 174. Taiwan Liposome Recent Developments/Updates
 Table 175. Santen Pharmaceutical Company Information
 Table 176. Santen Pharmaceutical Description and Business Overview
 Table 177. Santen Pharmaceutical Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Santen Pharmaceutical Ophthalmic Drug Delivery System Product
 Table 179. Santen Pharmaceutical Recent Developments/Updates
 Table 180. Envisia Therapeutics Company Information
 Table 181. Envisia Therapeutics Description and Business Overview
 Table 182. Envisia Therapeutics Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Envisia Therapeutics Ophthalmic Drug Delivery System Product
 Table 184. Envisia Therapeutics Recent Developments/Updates
 Table 185. Clearside Biomedical Company Information
 Table 186. Clearside Biomedical Description and Business Overview
 Table 187. Clearside Biomedical Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Clearside Biomedical Ophthalmic Drug Delivery System Product
 Table 189. Clearside Biomedical Recent Developments/Updates
 Table 190. Key Raw Materials Lists
 Table 191. Raw Materials Key Suppliers Lists
 Table 192. Ophthalmic Drug Delivery System Distributors List
 Table 193. Ophthalmic Drug Delivery System Customers List
 Table 194. Ophthalmic Drug Delivery System Market Trends
 Table 195. Ophthalmic Drug Delivery System Market Drivers
 Table 196. Ophthalmic Drug Delivery System Market Challenges
 Table 197. Ophthalmic Drug Delivery System Market Restraints
 Table 198. Research Programs/Design for This Report
 Table 199. Key Data Information from Secondary Sources
 Table 200. Key Data Information from Primary Sources
 Table 201. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ophthalmic Drug Delivery System
 Figure 2. Global Ophthalmic Drug Delivery System Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Ophthalmic Drug Delivery System Market Share by Type: 2024 & 2031
 Figure 4. Implantable Ophthalmic Drug Delivery Systems Product Picture
 Figure 5. Particulate Ophthalmic Drug Delivery Systems Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Ophthalmic Drug Delivery System Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Ophthalmic Drug Delivery System Market Share by Application: 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Clinics
 Figure 11. Ambulatory Surgical Centers
 Figure 12. Others
 Figure 13. Global Ophthalmic Drug Delivery System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Ophthalmic Drug Delivery System Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Ophthalmic Drug Delivery System Sales (2020-2031) & (K Units)
 Figure 16. Global Ophthalmic Drug Delivery System Average Price (US$/Unit) & (2020-2031)
 Figure 17. Ophthalmic Drug Delivery System Report Years Considered
 Figure 18. Ophthalmic Drug Delivery System Sales Share by Manufacturers in 2024
 Figure 19. Global Ophthalmic Drug Delivery System Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Ophthalmic Drug Delivery System Players: Market Share by Revenue in Ophthalmic Drug Delivery System in 2024
 Figure 21. Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Ophthalmic Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Ophthalmic Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 24. North America Ophthalmic Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Ophthalmic Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 28. Europe Ophthalmic Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Ophthalmic Drug Delivery System Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Ophthalmic Drug Delivery System Revenue Market Share by Region (2020-2031)
 Figure 36. China Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Ophthalmic Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Ophthalmic Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Ophthalmic Drug Delivery System Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Ophthalmic Drug Delivery System Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. U.A.E Ophthalmic Drug Delivery System Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Ophthalmic Drug Delivery System by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Ophthalmic Drug Delivery System by Type (2020-2031)
 Figure 58. Global Ophthalmic Drug Delivery System Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Ophthalmic Drug Delivery System by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Ophthalmic Drug Delivery System by Application (2020-2031)
 Figure 61. Global Ophthalmic Drug Delivery System Price (US$/Unit) by Application (2020-2031)
 Figure 62. Ophthalmic Drug Delivery System Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Ophthalmic Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Therapeutics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Pharmaceutical Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2025
Global Ocular Drug Delivery Devices Market Research Report 2025
Global Pharma Ophthalmic Market Research Report 2025
Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ophthalmic Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Common Drugs Use in Ophthalmology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ocular Drug Delivery Market Research Report 2025
Injectable Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Smart Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intranasal Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Eye Drug Market Insights Forecast to 2030
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmol Drug Market Research Report 2025
Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Unit Dose Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nanotechnology Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ophthalmology AI assisted Diagnosis Software Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions